IBEX - IBEX Downgraded After Dismal 4Q Results Analyst Expects Macro Woes To Persist | Benzinga
RBC Capital Markets analyst Daniel R. Perlin lowered IBEX Limited (NASDAQ: IBEX) to Sector Perform from Outperform, lowering the price target to $18 from $27.
IBEX recorded a dismal Q4, where earnings missed estimates in the face of a challenging macro-environment.
Given the ongoing industry pressures, the analyst downgraded the stock and would consider becoming more constructive should revenue growth reaccelerate.
Adj. EBITDA in Q4 was $6.5 million below the analyst's estimate, of which ...